Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
Crossref DOI link: https://doi.org/10.1186/s40200-015-0210-x
Published Online: 2015-10-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tamez, Hector E.
Tamez, Alejandra L.
Garza, Lucas A.
Hernandez, Mayra I.
Polanco, Ana C.
Text and Data Mining valid from 2015-10-09
Version of Record valid from 2015-10-09
Article History
Received: 12 January 2015
Accepted: 3 October 2015
First Online: 9 October 2015